BOSTON SCIENTIFIC CORP — Director's Dealing 2018

Jul 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-07-10

Reporting Person: Mirviss Jeffrey B. (SVP&Pres, Periph Intervent)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-10	Common Stock	M	33512.0000	$8.3000	Acquired	122674.0000	Direct
2018-07-10	Common Stock	S	33512.0000	$34.0002	Disposed	89162.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-10	Stock Option (Right to Buy)	$8.3000	M	33512.0000	Disposed	2019-02-24	Common Stock (33512.0000)	Direct

Footnotes

F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Represents the weighted average sale price. These shares were sold in multiple transactions at $34.00 and $34.01. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.